Navigation Links
Global Aptamers Market Technology Trend Analysis Market Report 2013-2018: Therapeutics, Diagnostics, Biosensors, Biomarker/Drug Discovery & Applications
Date:11/8/2013

DUBLIN, November 8, 2013 /PRNewswire/ --

Research and Markets
( http://www.researchandmarkets.com/research/tfh2m9/aptamers_market) has announced the addition of the "Global Aptamers Market Technology Trend Analysis Market Report 2013-2018" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)


The global aptamers market is valued at $287 million in 2013 and is expected to reach $2.1 billion by 2018.

Aptamers Market - Technology Trend Analysis By Applications - Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis - Global Forecasts to 2018

Aptamers existed alongside antibodies for two decades, but their market potential was not utilized to even a fraction of the same degree. However, the achievement of Macugen has given a boost to the aptamer field. The list of promising aptamers in the clinical trials pipeline estimates that these synthetic chemical antibodies will soon surpass monoclonal antibodies in therapeutics, diagnosis, and imaging. With technological merits over antibodies, the aptamers market is poised to grow at par with antibodies in the next 10-15 years.

Though there are just approximately 60 companies (biotech and pharmaceutical) working on aptamers, there are quite a number of research groups focused on the diverse applications of aptamers, particularly in studying key target molecules involved in cardiovascular diseases, infectious diseases, and against viral antigens. Hundreds of research articles have been published and a large number of patents granted and filed for this technology.

As well as a discussion on the properties of aptamers in the technological analysis, the basics on nucleic acid aptamers, peptide aptamers and the SELEX method for their synthesis are also discussed. Research applications are specifically discussed regarding aptamers use in flow cytometry, reagents and assays, mass spectrometry and western blotting. In addition, a number of therapeutic targets that are validated by basic research have been displayed under the therapeutics application segment. The complete value chain of the aptamers market is schematically represented and the significance of each stakeholder has been briefed.

Furthermore this report assesses the investor climate by tracking the complete investor network and collecting data on funds/grants and investments made in aptamers. Insights on current and future technological investment trends have also been discussed. The adoption and developmental potential of the aptamers technology market has been discussed on a geographic basis, i.e. North America, Europe, Asia-Pacific, and Rest of the world, by taking select countries that are poised to have a greater market value during the forecast period.

Scope of the Report

By Application

- Therapeutics
- Diagnostics
- Biosensors
- Drug discovery
- Biomarker discovery
- Research applications

By Aptamer Type

- Nucleic acid aptamers
- Peptide aptamers

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Aptamers - Technology Landscape Analysis 

4 Aptamers - Market Landscape Analysis

5 Technology Investment Potential

6 Aptamers - Technology Adoption And Development Potential

7 Aptamers Competitive Landscape

8 Intellectual Property And Research Strength Analysis

9 Analyst Insights And Recommendations 

10 Company Profiles

- AM Biotechnologies, Llc
- Aptagen, LIC
- Aptamatrix, Inc
- Aptamer Sciences Inc
- Aptamer Solutions Ltd
- Aptares AG
- Aptusbiotech
- Base Pair Biotechnologies
- Bioapter SL
- Cd Genomics
- Integrated Dna Technologies, Inc
- Lucerna, Inc
- NOXXON Pharma AG
- Neoventures Biotechnology Inc
- OTC Biotech
- Ophthotech Corporation
- Pfizer
- Regado Biosciences, Inc
- Somalogic, Inc
- Trilink Biotechnologies, Inc
- Vivonics

For more information visit http://www.researchandmarkets.com/research/tfh2m9/aptamers_market

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Polymerase Chain Reaction (PCR) - Products/Tools - A Global Market Watch, 2009-2015
2. Global Positron Emission Tomography Market 2012-2016: Industry Analysis, Size, Share, Growth, Trends and Forecast New Research Report Available at MarketResearchReports.biz
3. Biopharmaceuticals - A Global Market Overview
4. Regado Biosciences, Inc. Appoints World-Renowned Leader in Cardiovascular Research and Former Global Head of Cardiovascular Diseases for Merck & Co., to Board of Directors
5. Analysis of Global Biochips Industry, 2012-2018
6. Clinical Research Site-Expert Johan Karlberg to Lead ACRES Global Network Development
7. TVM Capital Group Announces Two-pronged Global Investment Strategy with Renewed MENA Focus
8. Global In Vitro Fertilization Market 2012-2016: Industry Analysis, Size, Share, Growth, Trends and Forecast New Research Report Available at MarketResearchReports.biz
9. Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis
10. Global Biophotonics Market & OSS BSS Industry 2012-2016 Reports
11. BCC Research Publishes a New Report On Global Markets for Flow Cytometry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
(Date:10/10/2017)... , ... October 10, 2017 , ... ... Center’s FirstHand program has won a US2020 STEM Mentoring Award. Representatives of the ... for Excellence in Volunteer Experience from US2020. , US2020’s mission is to change ...
(Date:10/10/2017)... 2017 SomaGenics announced the receipt of a ... RealSeq®-SC (Single Cell), expected to be the first commercially ... microRNAs) from single cells using NGS methods. The NIH,s ... accelerate development of approaches to analyze the heterogeneity of ... techniques for measuring levels of mRNAs in individual cells ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology:
(Date:5/23/2017)... , May 23, 2017  Hunova, the first robotic gym for the ... been officially launched in Genoa, Italy . The first ... and the USA . The technology was developed ... market by the IIT spin-off Movendo Technology thanks to a 10 million ... News Release, please click: ...
(Date:4/19/2017)... New York , April 19, 2017 ... competitive, as its vendor landscape is marked by the ... the market is however held by five major players ... Safran. Together these companies accounted for nearly 61% of ... of the leading companies in the global military biometrics ...
(Date:4/11/2017)... GARDENS, Fla. , April 11, 2017 /PRNewswire/ ... management and secure authentication solutions, today announced that ... by Intelligence Advanced Research Projects Activity (IARPA) to ... IARPA,s Thor program. "Innovation has been ... and IARPA,s Thor program will allow us to ...
Breaking Biology News(10 mins):